3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Hyperthermia
20
Sarcoma
8
Uterine Cervical Neoplasms
7
Breast Neoplasms
6
Rectal Neoplasms
5
Prostatic Neoplasms
5
Ovarian Neoplasms
5
Colonic Neoplasms
5
Neoplasm Metastasis
4
Head and Neck Neoplasms
4
Neoplasms
3
Melanoma
3
Lung Neoplasms
3
Carcinoma, Hepatocellular
3
Urinary Bladder Neoplasms
2
Sarcoma, Synovial
2
Neurofibrosarcoma
2
Liver Neoplasms
2
Liposarcoma
2
Leiomyosarcoma
2
Histiocytoma, Malignant Fibrous
2
Fibrosarcoma
2
Colorectal Neoplasms
2
Carcinoma, Ovarian Epithelial
2
Unspecified Adult Solid Tumor, Protocol Specific
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumors
1
Small Cell Lung Carcinoma
1
Sarcoma, Clear Cell
1
Sarcoma, Alveolar Soft Part
1
Interventions
Metformin
149
Clomiphene
51
Letrozole
39
Inositol
35
Folic Acid
18
Exercise
17
Progesterone
15
Ethinyl Estradiol
13
Chorionic Gonadotropin
13
Caloric Restriction
13
drospirenone and ethinyl estradiol combination
12
Estradiol
12
Contraceptives, Oral
11
cetrorelix
10
Pioglitazone
10
High-Intensity Interval Training
10
Tablets
9
Spironolactone
9
Cholecalciferol
9
Triptorelin Pamoate
8
Diet
8
Vitamin D
7
Thioctic Acid
7
Menotropins
7
Liraglutide
7
Acupuncture Therapy
7
drospirenone
6
Ovidrel
6
Gonadotropins
6
Flutamide
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Polycystic Ovary Syndrome
×
Diathermy
×
Clear all
NCT03644524
2018-08-23
CMH
University of Oregon
Phase NA
Completed
20 enrolled